Institutional investors have a lot riding on Relmada Therapeutics, Inc....

Published on 21 Jul 2024 on Simply Wall St. · via Yahoo Finance

Institutional investors have a lot riding on Relmada Therapeutics, Inc....

Key Insights

Institutions' substantial holdings in Relmada Therapeutics implies that they have significant influence over the company's share priceA total of 25 investors have a majority stake in the company with 46% ownershipOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

Read the rest of the article

NASDAQ.RLMD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights: Navigating...

Despite a decrease in cash reserves, Relmada Therapeutics Inc (RLMD) remains focused on pivotal C...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Insider Buying: CFO Maged Shenouda Acquires Shares of Relmada Therapeutics Inc...

On September 11, 2024, Maged Shenouda, the Chief Financial Officer of Relmada Therapeutics Inc (N...

GuruFocus.com · via Yahoo Finance 21 Sep 2024

Relmada Therapeutics Inc (RLMD) CEO Sergio Traversa Acquires 140,000 Shares

This transaction was documented in an SEC Filing. Following this acquisition, the insider now own...

GuruFocus.com · via Yahoo Finance 17 Sep 2024

Institutional investors have a lot riding on Relmada Therapeutics, Inc....

Key Insights Institutions' substantial holdings in Relmada Therapeutics implies that they have si...

Simply Wall St. · via Yahoo Finance 21 Jul 2024

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2024 Earnings Call Transcript May 10, 2024 Relmada Th...

Insider Monkey via Yahoo Finance 11 May 2024

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada ...

Insider Monkey via Yahoo Finance 20 Mar 2024

Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week,...

Key Insights Relmada Therapeutics' significant individual investors ownership suggests that the k...

Simply Wall St. · via Yahoo Finance 17 Feb 2024

Relmada Therapeutics Inc CEO Sergio Traversa Acquires 100,000 Shares

In a recent transaction on January 31, 2024, CEO Sergio Traversa of Relmada Therapeutics Inc (NAS...

GuruFocus.com via Yahoo Finance 29 Jan 2024

Relmada Therapeutics CEO & Director Acquires 69% More Stock

Investors who take an interest in Relmada Therapeutics, Inc. (NASDAQ:RLMD) should definitely note...

Simply Wall St. · via Yahoo Finance 17 Jan 2024

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2023 Earnings Call Transcript

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2023 Earnings Call Transcript November 9, 2023 Relmad...

Insider Monkey via Yahoo Finance 10 Nov 2023

News

Institutional investors have a lot riding on Relmada Therapeutics, Inc....

NASDAQ.RLMD price evolution

Want to become a better investor?